Vista Pharmaceuticals

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue0.001.402.113.551.72
Expenses0.895.083.415.143.93
EBITDA-0.34-3.19-0.79-1.09-1.72
EBIT-0.49-3.36-0.96-1.27-1.90
Profit Before Tax-0.89-3.67-1.28-1.59-2.20
Net Profit-0.96-3.71-0.95-2.02-1.63
Financial Ratios
Operating Profit Margin0.00%-320.00%-39.90%-31.41%-101.18%
Net Profit Margin0.00%-371.00%-47.98%-58.21%-95.88%
Earning Per Share (Diluted)-0.27-0.59-0.15-0.34-0.26
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ